Researcher comment: The KEYNOTE-604 trial | Charles Rudin

(5:2)

Charles Rudin, MD, PhD, discusses the Keynote-604 study and the role of Keytruda in ES-SCLC

(53)

Charles Rudin, MD, PhD, shares outcomes of the Keynote 604 study to investigating Keytruda and chemo

(2:47)

KEYNOTE-604: Pembrolizumab plus etoposide and platinum as a first-line therapy for extensive-sta...

(4:20)

Dr. Rudin on the Design of the KEYNOTE-604 Trial in ES-SCLC

(1:2)

Charles Rudin, MD, PhD, shares the take home message regarding Keynote-604 for lung cancer treatment

(46)

KEYNOTE-604 and ECOG-ACRIN 5161 Trials for ES-SCLC

(3:34)

Lester Young Quartet. Sometimes I´m Happy (Keynote 604, 1943)

(3:7)

Lung Cancer Video Library - LIU - Immunotherapy for Small Cell Lung Cancer

(7:5)

1st-line Pembro or Placebo Combined with Etoposide \u0026 Platinum for ES-SCLC: KEYNOTE-604 Long-Term...

(6:52)

Recent Progress in the Treatment of SCLC

(5:7)

Dr. Gerald Paris presents abstracts on lung cancer

(4:56)

Chemoimmunotherapy for ES SCLC: CASPIAN Trial

(4:57)

Announcing Opening \u0026 Closing Keynotes at #Summit4CI 2019

(14)

Focused on Delivering The Best Experience Ever - DailyVee 604 | VeeCon Day 2

(16:13)

Expert comment: 5-year update of KEYNOTE-001 | David Graham

(1:27)

Vancouver Women's Expo 2017 with SOS My Space's Keynote

(24:34)

4M: Keynote Address - Robert Cerfolio, MD MBA

(39:6)

Basics of Immunotherapy in Small Cell Lung Cancer (SCLC)

(16:50)

S1 Episode 5: Small Cell Lung Cancer: What Are the First-line and Second-line Treatment Options?

(22:41)